Rituximab, Cyclophosphamide, and Pegfilgrastim in Treating Patients With Leukemia or Non-Hodgkin's Lymphoma
Clinical trial NCT00278161 · COMPLETED
Trial details
- NCT number
- NCT00278161
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-01-01
- Primary completion
- 2009-12-01
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.